MICHAEL ALAN LAFLAMME
Medical Practice at Pacific St, Seattle, WA
License number
Washington MD00041158
Category
Medical Practice
Type
Anatomic Pathology & Clinical Pathology
Address
Address
1959 NE Pacific St, Seattle, WA 98195
Phone
(206) 598-6400
Personal information
See more information about MICHAEL ALAN LAFLAMME at radaris.comName
Address
Phone
3401 Wallingford Ave N APT 403, Seattle, WA 98103
4740 40Th St, Seattle, WA 98105
Professional information
See more information about MICHAEL ALAN LAFLAMME at trustoria.com
Associate Professor At University Of Washington
Associate Professor At University Of Washington
Position:
Associate Professor at University of Washington
Location:
Greater Seattle Area
Industry:
Research
Work:
University of Washington
since Jul 2012
-
Associate Professor
University of Washington
Jul 2006 - Jun 2012
-
Assistant Professor
Education:
Emory University School of Medicine 1991 - 1999
MD, PhD, Physiology & Pharmacology Georgetown University 1987 - 1991
Bachelor of Science (BS), Physics
MD, PhD, Physiology & Pharmacology Georgetown University 1987 - 1991
Bachelor of Science (BS), Physics
Michael Alan Laflamme, Seattle WA
Michael Alan Laflamme, Seattle WA
Specialties:
Anatomic Pathology, Anatomic Pathology & Clinical Pathology
Work:
University Of Washington Medical Ctr
1959 Ne Pacific St, Seattle, WA 98195 Harborview Medical Center
325 9Th Ave, Seattle, WA 98104
1959 Ne Pacific St, Seattle, WA 98195 Harborview Medical Center
325 9Th Ave, Seattle, WA 98104
Education:
Emory University(1999)
Michael Alan Laflamme, Seattle WA
Michael Alan Laflamme, Seattle WA
Specialties:
Pathologist
Address:
University Of Washington Medical Ctr, Seattle, WA 98195
Education:
Doctor of Medicine
Board certifications:
American Board of Pathology Certification in Anatomic Pathology (Pathology)
Dr. Michael A Laflamme, Seattle WA - MD (Doctor of Medicine)
Dr. Michael A Laflamme, Seattle WA - MD (Doctor of Medicine)
Specialties:
Anatomic Pathology
Address:
1959 NE Pacific St SUITE 356100, Seattle 98195
(206) 598-6400 (Phone)
UNIVERSITY OF WASHINGTON
1959 NE Pacific St, Seattle 98195
(206) 598-3300 (Phone), (206) 667-6643 (Fax)
(206) 598-6400 (Phone)
UNIVERSITY OF WASHINGTON
1959 NE Pacific St, Seattle 98195
(206) 598-3300 (Phone), (206) 667-6643 (Fax)
Certifications:
Anatomic Pathology, 2003
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
1959 NE Pacific St SUITE 356100, Seattle 98195
UNIVERSITY OF WASHINGTON
1959 NE Pacific St, Seattle 98195
Harborview Medical Center
325 9Th Ave, Seattle 98104
UNIVERSITY OF WASHINGTON
1959 NE Pacific St, Seattle 98195
Harborview Medical Center
325 9Th Ave, Seattle 98104
Education:
Medical School
Emory University
Emory University
Induction Of Human Embryonic Stem Cell Derived Cardiac Pacemaker Or Chamber-Type Cardiomyocytes By Manipulation Of Neuregulin Signaling
Induction Of Human Embryonic Stem Cell Derived Cardiac Pacemaker Or Chamber-Type Cardiomyocytes By Manipulation Of Neuregulin Signaling
US Patent:
8603817, Dec 10, 2013
Filed:
Nov 3, 2009
Appl. No.:
12/611569
Inventors:
Michael A. LaFlamme - Seattle WA, US
Wei-Zhong Zhu - Seattle WA, US
Wei-Zhong Zhu - Seattle WA, US
Assignee:
University of Washington - Seattle WA
International Classification:
C12N 5/00
US Classification:
435377, 435375
Abstract:
The present invention is directed to methods of producing cardiomyocytes having a nodal/pacemaker phenotype and cardiomyocytes having an atrial/ventricular phenotype. Isolated populations of nodal/pacemaker and atrial/ventricular cardiomyocytes are also disclosed. Methods of treating a subject having cardiac arrhythmia and a subject in need of cardiac tissue repair using the isolated populations of nodal/pacemaker cardiomyocytes and atrial/ventricular cardiomyocytes, respectively, are also disclosed.
Formulation To Improve Survival Of Transplanted Cells
Formulation To Improve Survival Of Transplanted Cells
US Patent:
2007016, Jul 19, 2007
Filed:
Jan 19, 2006
Appl. No.:
11/336502
Inventors:
Charles Murry - Seattle WA, US
Michael Laflamme - Seattle WA, US
Michael Laflamme - Seattle WA, US
International Classification:
A61K 35/12, C12N 5/08
US Classification:
424093700, 435366000
Abstract:
The survival of cells during transplantation is enhanced. Cells to be transplanted are administered in a formulation that provides two ore more survival enhancing factors. Optionally, prior to administration, the cells are cultured in the presence of factors that enhance survival, and may be heat shocked prior to transplantation.
Purified Compositions Of Stem Cell Derived Differentiating Cells
Purified Compositions Of Stem Cell Derived Differentiating Cells
US Patent:
2006004, Feb 23, 2006
Filed:
Aug 17, 2004
Appl. No.:
10/920795
Inventors:
Charles Murry - Seattle WA, US
Michael Laflamme - Seattle WA, US
Michael Laflamme - Seattle WA, US
International Classification:
C12N 5/08, G01N 33/567
US Classification:
435377000, 435366000, 435007200
Abstract:
Viable differentiating cells from in vitro cultures of stem cells are selected for by partial dissociation to provide cell aggregates. Aggregates comprising cells of interest are selected for phenotypic features using methods that substantially maintain the cell to cell contacts in the aggregate.